Intrinsiqq
Cadre Holdings Inc. logo

Cadre Holdings Inc. (CDRE) Insider Trading

Last 12 months

Insiders sold $80.1M and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. CEO AND CHAIRMAN Warren B Kanders sold $52.4M on Nov 17, 2025, 10% of their stake, outside a plan. No executive or director has bought shares on the open market in the last two years.

Net open-market
−$80.1M
0 buys · 10 sales
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
0 / 3
executives and directors
Last open-market buy
None
in the last two years

Get an email when CDRE's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Aug 24 – 25No plan
    Warren B Kanders
    CEO AND CHAIRMAN · sold 200,000 at avg $32.61
    $6.52M
    1.0% of stake
  • Aug 17No plan
    Brad Williams
    PRESIDENT · sold 88,742 at avg $33.24
    $2.95M
    34% of stake
  • Jun 18 – 22No plan
    Warren B Kanders
    CEO AND CHAIRMAN · sold 75,000 at avg $27.57
    $2.07M
    0.4% of stake
  • Jun 15 – 17No plan
    Warren B Kanders
    CEO AND CHAIRMAN · sold 225,000 at avg $29.06
    $6.54M
    1.1% of stake
  • Mar 20 – 23No plan
    Warren B Kanders
    CEO AND CHAIRMAN · sold 200,000 at avg $31.67
    $6.33M
    0.9% of stake
  • Dec 12, 2025No plan
    Blaine Browers
    CHIEF FINANCIAL OFFICER · sold 20,435 at $43.79
    $895k
    24% of stake
  • Dec 10, 2025No plan
    Brad Williams
    PRESIDENT · sold 24,000 at $42.99
    $1.03M
    30% of stake
  • Nov 17, 2025No plan
    Warren B Kanders
    CEO AND CHAIRMAN · sold 1,343,941 at avg $39.00
    $52.4M
    10% of stake
  • Nov 13, 2025No plan
    Brad Williams
    PRESIDENT · sold 27,370 at $43.62
    $1.19M
    26% of stake
  • Oct 24, 202510b5-1 plan
    Brad Williams
    PRESIDENT · sold 4,132 at $43.00
    $178k
    3.7% of stake
  • Oct 14, 202510b5-1 plan
    Brad Williams
    PRESIDENT · sold 4,132 at $40.00
    $165k
    3.6% of stake
  • Sep 23, 202510b5-1 plan
    Brad Williams
    PRESIDENT · sold 4,132 at $37.00
    $153k
    3.5% of stake
  • Jun 23, 2025No plan
    Warren B Kanders
    CEO AND CHAIRMAN · sold 25,000 at $32.78
    $820k
    0.2% of stake
  • Jun 18, 2025 – Jun 20, 2025No plan
    Warren B Kanders
    CEO AND CHAIRMAN · sold 100,000 at avg $33.48
    $3.35M
    0.5% of stake
  • Jun 3, 2025 – Jun 4, 2025No plan
    Warren B Kanders
    CEO AND CHAIRMAN · sold 125,000 at avg $33.61
    $4.2M
    0.6% of stake
  • May 30, 2025No plan
    Warren B Kanders
    CEO AND CHAIRMAN · sold 50,000 at $32.75
    $1.64M
    0.4% of stake
  • May 27, 2025 – May 28, 2025No plan
    Warren B Kanders
    CEO AND CHAIRMAN · sold 100,000 at avg $32.91
    $3.29M
    0.4% of stake
  • May 22, 2025 – May 23, 2025No plan
    Warren B Kanders
    CEO AND CHAIRMAN · sold 100,000 at avg $32.92
    $3.29M
    0.4% of stake
  • May 20, 2025No plan
    Warren B Kanders
    CEO AND CHAIRMAN · sold 100,000 at $34.86
    $3.49M
    0.8% of stake
  • Mar 20, 2025 – Mar 21, 2025No plan
    Warren B Kanders
    CEO AND CHAIRMAN · sold 100,000 at avg $31.43
    $3.14M
    0.4% of stake
  • Mar 18, 2025 – Mar 19, 2025No plan
    Warren B Kanders
    CEO AND CHAIRMAN · sold 150,000 at avg $31.89
    $4.78M
    1.2% of stake
  • Mar 14, 2025 – Mar 17, 2025No plan
    Warren B Kanders
    CEO AND CHAIRMAN · sold 200,000 at avg $33.12
    $6.62M
    0.8% of stake
  • Dec 16, 2024No plan
    Warren B Kanders
    CEO AND CHAIRMAN · sold 12,133 at $36.22
    $439k
    <0.1% of stake
  • Dec 13, 2024No plan
    Warren B Kanders
    CEO AND CHAIRMAN · sold 25,000 at $35.29
    $882k
    0.2% of stake
  • Dec 11, 2024No plan
    Warren B Kanders
    CEO AND CHAIRMAN · sold 25,000 at $35.32
    $883k
    0.2% of stake
  • Dec 9, 2024 – Dec 10, 2024No plan
    Warren B Kanders
    CEO AND CHAIRMAN · sold 50,000 at avg $35.27
    $1.76M
    0.2% of stake
  • Dec 5, 2024 – Dec 6, 2024No plan
    Warren B Kanders
    CEO AND CHAIRMAN · sold 50,000 at avg $35.75
    $1.79M
    0.2% of stake
  • Dec 3, 2024No plan
    Brad Williams
    PRESIDENT · sold 25,000 at $34.24
    $856k
    18% of stake
  • Dec 2, 2024 – Dec 3, 2024No plan
    Warren B Kanders
    CEO AND CHAIRMAN · sold 75,589 at avg $34.23
    $2.59M
    0.3% of stake
  • Nov 29, 2024 – Dec 3, 2024No plan
    Nicolas Sokolow
    Director · sold 18,905 at avg $33.89
    $641k
    2.1% of stake
  • Nov 27, 2024No plan
    Warren B Kanders
    CEO AND CHAIRMAN · sold 49,411 at $33.56
    $1.66M
    0.4% of stake
  • Nov 26, 2024No plan
    Warren B Kanders
    CEO AND CHAIRMAN · sold 50,000 at $33.55
    $1.68M
    0.4% of stake
  • Nov 22, 2024 – Nov 25, 2024No plan
    Nicolas Sokolow
    Director · sold 6,095 at avg $33.40
    $204k
    0.7% of stake
  • Nov 21, 2024 – Nov 22, 2024No plan
    Warren B Kanders
    CEO AND CHAIRMAN · sold 100,000 at avg $33.01
    $3.3M
    0.4% of stake
  • Nov 19, 2024 – Nov 20, 2024No plan
    Warren B Kanders
    CEO AND CHAIRMAN · sold 67,036 at avg $32.11
    $2.15M
    0.3% of stake
  • Nov 15, 2024 – Nov 18, 2024No plan
    Warren B Kanders
    CEO AND CHAIRMAN · sold 57,964 at avg $32.60
    $1.89M
    0.2% of stake
  • Nov 12, 2024No plan
    Blaine Browers
    Chief Financial Officer · sold 30,000 at $34.06
    $1.02M
    28% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CDRE, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Orthopedic, Prosthetic & Surgical Appliances & Supplies

Spot a number that looks wrong? Check it in CDRE's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CDRE

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.